TransCode Therapeutics, Inc. Stock Forecast
Evaluation of TransCode Therapeutics, Inc. stock downgraded after the last trading session.
(Updated on Apr 24, 2024)
The TransCode Therapeutics, Inc. stock price fell by -4.35% on the last day (Wednesday, 24th Apr 2024) from $0.460 to $0.440. During the last trading day the stock fluctuated 9.50% from a day low at $0.420 to a day high of $0.460. The price has fallen in 8 of the last 10 days and is down by -31.32% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -9 thousand shares and in total, 90 thousand shares were bought and sold for approximately $39.65 thousand.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.433 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -20.03% during the next 3 months and, with a 90% probability hold a price between $0.346 and $0.515 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
RNAZ Signals & Forecast
There are few to no technical positive signals at the moment. The TransCode Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.479 and $0.627. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 07, 2024, and so far it has fallen -39.74%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for TransCode Therapeutics, Inc. stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0399 between high and low, or 9.50%. For the last week the stock has had daily average volatility of 9.05%.
TransCode Therapeutics, Inc. is oversold on RSI14 (6). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (RNAZ) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect TransCode Therapeutics, Inc. to open at $0.440, and during the day (based on 14 day Average True Range), to move between $0.390 and $0.489, which gives a possible trading interval of +/-$0.0495 (+/-11.25%) up or down from last closing price. If TransCode Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 22.49% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $0.459, some $0.0191 (4.34%) from the current price of $0.440, our system finds the risk reward not very attractive.
Is TransCode Therapeutics, Inc. stock A Buy?
TransCode Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.
Current score: -6.241 Strong Sell Candidate Downgraded
Predicted Opening Price for TransCode Therapeutics, Inc. of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $0.440 ( 0.0076%) | $0.440 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for RNAZ
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.480 | 9.08 % | |
| R2 | 0.465 | 5.61 % | ||
| R1 | 0.455 | 3.47 % | ||
| Current price: | 0.440 | |||
| Support | S1 | 0.425 | -3.46 % | |
| S2 | 0.415 | -5.60 % | ||
| S3 | 0.400 | -9.06 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.536 | 21.91 % | |
| R2 | 0.505 | 14.80 % | ||
| R1 | 0.459 | 4.34 % | ||
| Current price | 0.440 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy TransCode Therapeutics, Inc. Stock.
